TherapeuticsMD Inc.

NASDAQ: TXMD · Real-Time Price · USD
1.17
0.02 (1.72%)
At close: Aug 15, 2025, 3:58 PM
1.18
0.86%
After-hours: Aug 15, 2025, 07:44 PM EDT

TherapeuticsMD Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-2.18M -10.28M 1.07M -172.41M
Depreciation & Amortization
509K 922K 1.19M 4.09M
Stock-Based Compensation
264K 1.27M 11.57M 18.13M
Other Working Capital
1.43M -13.18M -2.88M 5.27M
Other Non-Cash Items
918K -23.95M -13.83M 7.49M
Deferred Income Tax
n/a n/a n/a 533K
Change in Working Capital
1.66M -15.31M -4.09M -520K
Operating Cash Flow
1.17M -48.14M -4.08M -142.69M
Capital Expenditures
n/a n/a -355K -2.22M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 223.83M -2.19M
Investing Cash Flow
n/a n/a 223.48M -2.22M
Debt Repayment
n/a n/a -219.43M -50M
Common Stock Repurchased
n/a n/a -38.66M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 3.15M -1.27M -4.8M
Financial Cash Flow
n/a 3.15M -235.21M 129.55M
Net Cash Flow
732K -44.99M -15.8M -15.36M
Free Cash Flow
1.17M -48.14M -4.43M -144.92M